日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology

激素受体阳性/HER2阴性乳腺癌试验中的动态生物标志物：精准肿瘤学的新希望

期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-026-00904-5
Di Grazia, Giuseppe; Sánchez-Bayona, Rodrigo; Casals-Pascual, Climent; Pascual, Tomás; Generali, Daniele; Gennari, Alessandra; Vigneri, Paolo; Harbeck, Nadia; Cortés, Javier; Prat, Aleix; Schettini, Francesco
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2026
文献求助 收藏

Targeting leukemic stem and progenitor cells expressing different BCR::ABL1 levels: antileukemic activity of asciminib with or without TKIs

靶向表达不同 BCR::ABL1 水平的白血病干细胞和祖细胞：asciminib 联合或不联合 TKI 的抗白血病活性

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2026.1780054
Massimino, Michele; Tirrò, Elena; Romano, Chiara; Stella, Stefania; Tomarchio, Cristina; Vitale, Silvia Rita; Manzella, Livia; Di Raimondo, Francesco; Stagno, Fabio; Vigneri, Paolo
发育与干细胞
ABL1
白血病
干细胞
BCR
细胞生物学
发表日期：2026
文献求助 收藏

Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review

选择性AKT激酶抑制剂Capivasertib治疗转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌的临床前原理、临床疗效和安全性：一项实用性叙述性综述

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol33040198
Valerio, Maria Rosaria; Sambataro, Daniela; Martorana, Federica; Greco, Martina; Mesi, Chiara; Gebbia, Vittorio; Vigneri, Paolo; Scandurra, Giuseppa
信号转导
AKT
Human
免疫/内分泌
乳腺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level

羟基脲预处理对一线慢性粒细胞白血病治疗无益，且有证据表明 BCR::ABL1 转录水平发生定量变化

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26051840
Stagno, Fabio; Stella, Stefania; Leotta, Salvatore; Caserta, Santino; Vitale, Silvia Rita; Markovic, Uros; Tomarchio, Cristina; Mirabile, Giuseppe; Russo, Sabina; Massimino, Michele; Vigneri, Paolo; Manzella, Livia; Di Raimondo, Francesco; Allegra, Alessandro
ABL1
粒细胞
白血病
BCR
细胞生物学
发表日期：2025
文献求助 收藏

The Coiled Coil and C2 Domains Modulate BCR Localization and BCR-ABL1 Compartmentalization, Transforming Activity and TKI Responsiveness.

卷曲螺旋和 C2 结构域调节 BCR 定位和 BCR-ABL1 区室化、转化活性和 TKI 反应性

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26146591
Massimino Michele, Stella Stefania, Romano Chiara, Buffa Pietro, Tirrò Elena, Drago Melissa, Manzella Livia, Tomarchio Cristina, Vitale Silvia Rita, Di Raimondo Francesco, Vigneri Paolo
BCR
ABL1
发表日期：2025
文献求助 收藏

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma

优化的NGS工作流程定义了葡萄膜黑色素瘤患者的基于基因的预后类别

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom15010146
Massimino, Michele; Tirrò, Elena; Stella, Stefania; Tomarchio, Cristina; Di Bella, Sebastiano; Vitale, Silvia Rita; Conti, Chiara; Puglisi, Marialuisa; Di Crescenzo, Rosa Maria; Varricchio, Silvia; Merolla, Francesco; Broggi, Giuseppe; Martorana, Federica; Turdo, Alice; Gaggianesi, Miriam; Manzella, Livia; Russo, Andrea; Stassi, Giorgio; Caltabiano, Rosario; Staibano, Stefania; Vigneri, Paolo
黑色素瘤
发表日期：2025
文献求助 收藏

Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review

释放免疫检查点抑制剂在HR+/HER2-乳腺癌中的潜力：系统性综述

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17172940
Di Grazia, Giuseppe; Dri, Arianna; Grieco, Angela; Martinelli, Claudia; Palleschi, Michela; Martorana, Federica; Barchiesi, Giacomo; Arpino, Grazia; De Angelis, Carmine; De Laurentiis, Michelino; Del Mastro, Lucia; Puglisi, Fabio; Vigneri, Paolo; Giuliano, Mario
免疫/内分泌
HER2
Checkpoint
乳腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Unveiling Prostate-Specific Membrane Antigen's Potential in Breast Cancer Management

揭示前列腺特异性膜抗原在乳腺癌治疗中的潜力

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17030456
Motta, Lucia; Puglisi, Marialuisa; Pavone, Giuliana; Motta, Gianmarco; Martorana, Federica; Bambaci, Michelangelo; Aricò, Demetrio; Vigneri, Paolo
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis

帕博西尼联合内分泌治疗治疗HR阳性/HER2阴性转移性乳腺癌的真实世界研究与随机研究的疗效比较：系统评价和荟萃分析

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkaf083
Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sánchez-Bayona, Rodrigo; Pascual, Tomás; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Novel protocol for mapping virus integration sites in genes involved in therapy resistance.

用于绘制与治疗耐药性相关的基因中病毒整合位点的新方案

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-05160-4
Massimino Michele, Huang Zhangzan, Helmijr Jean, Muritti Camilla, Uijtdewillegen Anna, Vigneri Paolo, Martens John W M, Jansen Maurice P H M
微生物学
治疗耐药
发表日期：2025
文献求助 收藏